Eliem Therapeutics Cash from Investing (TTM) Trends

Eliem Therapeutics Inc (ELYM)

10.16 +1.76 (+21.04%) USD | NASDAQ | May 03, 16:00

10.14 -0.02 (-0.15%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2023	68.98M
September 30, 2023	46.51M
June 30, 2023	26.98M
March 31, 2023	44.27M
December 31, 2022	34.44M
September 30, 2022	12.11M

Date	Value
June 30, 2022	-103.32M
March 31, 2022	-119.00M
December 31, 2021	-114.97M
September 30, 2021	-98.84M
June 30, 2021	8.078M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-119.00M

Minimum

Mar 2022

68.98M

Maximum

Dec 2023

-17.71M

Average

12.11M

Median

Sep 2022

Cash from Investing (TTM) Benchmarks